Cresco Labs Q3 EPS Lifted by Alliance Global Partners

Cresco Labs Inc. (OTCMKTS:CRLBF) – Research analysts at Alliance Global Partners boosted their Q3 2025 earnings estimates for Cresco Labs in a research report issued on Wednesday, March 12th. Alliance Global Partners analyst A. Grey now expects that the company will post earnings per share of ($0.02) for the quarter, up from their previous estimate of ($0.03). The consensus estimate for Cresco Labs’ current full-year earnings is ($0.20) per share. Alliance Global Partners also issued estimates for Cresco Labs’ Q4 2025 earnings at ($0.01) EPS, FY2025 earnings at ($0.09) EPS and FY2026 earnings at ($0.08) EPS.

Separately, Atb Cap Markets cut Cresco Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, December 9th. Three analysts have rated the stock with a hold rating, one has assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $3.00.

Cresco Labs Stock Down 0.8 %

Shares of OTCMKTS CRLBF opened at $0.73 on Monday. The stock has a market cap of $358.29 million, a PE ratio of -3.67 and a beta of 1.79. The business has a fifty day moving average of $0.88 and a two-hundred day moving average of $1.19. Cresco Labs has a 52-week low of $0.70 and a 52-week high of $2.60. The company has a debt-to-equity ratio of 1.80, a quick ratio of 1.39 and a current ratio of 1.97.

Cresco Labs (OTCMKTS:CRLBF) last posted its quarterly earnings results on Friday, March 14th. The company reported ($0.01) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.01). Cresco Labs had a negative net margin of 9.15% and a negative return on equity of 16.52%. The firm had revenue of $176.00 million for the quarter, compared to the consensus estimate of $172.10 million.

Cresco Labs Company Profile

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.